Lunit
About Lunit
Lunit is a leading medical AI software company dedicated to advancing total cancer care through innovative artificial intelligence solutions. Their comprehensive platform integrates AI across the entire cancer care continuum, from early detection and diagnosis to personalized treatment decisions and drug development.
For diagnostic imaging, Lunit offers the INSIGHT suite, which includes AI solutions for chest X-rays (Lunit INSIGHT CXR), mammography (Lunit INSIGHT MMG), and 3D digital breast tomosynthesis (Lunit INSIGHT DBT). These tools are designed to assist radiologists by enhancing the accuracy and efficiency of cancer screening and detection, identifying subtle abnormalities that might be missed by the human eye. The company’s solutions are clinically validated and have received FDA clearance and CE Mark certification, demonstrating their reliability and efficacy in real-world clinical settings globally.
In the realm of precision oncology, Lunit’s SCOPE platform provides AI-powered biomarker analysis for immuno-oncology. This includes solutions like Lunit SCOPE IO for tumor microenvironment analysis, Lunit SCOPE PD-L1 for PD-L1 expression quantification, and Lunit SCOPE IHC Suite for IHC quantification. These tools aid pathologists and researchers in predicting patient responses to immunotherapy, guiding treatment strategies, and accelerating the discovery and development of new antibody-based therapies and companion diagnostics. Lunit partners with global healthcare and biopharma leaders to deploy its AI products and drive innovation in cancer care.
Focus Areas
Business Intelligence
| Key Investors | Intervest, Guardant Health, HealthQuest Capital, Casdin Capital, American Cancer Society BrightEdge, Tybourne Capital Management, NSG Ventures, Naver, Softbank Ventures Asia, Legend Capital, IMM Investment, Kakao Ventures, Mirae Asset Venture Investment, Shinhan Investment |
| Partnerships | Microsoft, AstraZeneca, Philips, Guardant Health, Agfa, GE Healthcare, Fujifilm, U.S. National Cancer Institute, Radiobotics, Lexington Clinic, CellCarta, Daiichi Sankyo, Labcorp |
| Acquisitions | Volpara Health Technologies (2024), Prognosia (2025) |
| Technology | Cloud-based imaging AI platform (Lunit INSIGHT), AI-powered digital pathology platform (Lunit SCOPE), Modular AI ecosystem, Multimodal AI (imaging, clinical, tissue, molecular data), Foundation model approach |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, Lunit's AI solutions act as a powerful 'second pair of eyes,' significantly enhancing diagnostic confidence and accuracy by detecting 5-13% more cancers in mammography and identifying subtle abnormalities in chest X-rays that might otherwise be overlooked. This leads to earlier detection, which is crucial for improved patient outcomes and can reduce unnecessary patient callbacks. The AI streamlines workflows by providing faster image interpretation, reducing cognitive load, and enabling efficient triage, which is particularly beneficial in high-volume settings or amidst radiologist shortages. In oncology, Lunit SCOPE offers quantifiable insights from tissue, aiding in biomarker discovery and personalized treatment strategies. The systems are designed for seamless integration into existing PACS/RIS and clinical workflows, minimizing disruption and maximizing utility. Furthermore, the extensive clinical validation and regulatory approvals (FDA, CE-MDR) provide a strong foundation of trust and reliability for clinical adoption.
Lunit's AI solutions are built for seamless and stable integration into existing radiology and pathology environments. They are compatible with standard DICOM formats and integrate with leading imaging manufacturers, PACS/RIS vendors, and digital health platforms. Key partnerships include collaborations with GE Healthcare (e.g., Thoracic Care Suite, Centricity PACS, Edison Open AI Orchestrator), Fujifilm, and cloud-based PACS providers like Emergent Connect, ensuring flexible deployment options and dedicated technical support.
What the Web Says
Lunit is a South Korean medical AI company specializing in cancer diagnostics and therapeutics, particularly with its INSIGHT suite for analyzing chest X-rays and mammograms. The company's products are designed to assist radiologists in detecting early signs of cancer, prioritizing urgent cases, and improving workflow efficiency. Lunit's AI has demonstrated high accuracy in detecting various abnormalities, including tuberculosis, and has received positive feedback for its potential to reduce radiologist workload and enhance diagnostic precision.
Overall: PositiveStrengths
- High accuracy in cancer detection (97-99%) and abnormality identification.
- Reduces radiologist workload and improves efficiency.
- Aids in early detection and prioritization of urgent cases.
- Seamless integration into existing medical imaging workflows.
- Strong clinical validation through numerous studies and collaborations.
- Maintains high sensitivity across diverse populations and thresholds, crucial for resource-limited settings.
Limitations
- Pricing information is not publicly available and requires direct contact.
- Limited details on inputs/outputs or integration from available information.
- Deployment depth may vary by health system.
- Some Reddit discussions express concern about AI potentially replacing radiologists.
- Accuracy claims should be independently verified.
Based on reviews from: Elion, Neura Market, Techjockey.com, SoftFinders, Slashdot, Clinical Trials Arena, The Lancet Digital Health, Indeed.com, Reddit, ResponsibilityReports.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about Lunit.
Videos load interactively. If none appear, search YouTube for Lunit →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Lunit.
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]